Search research articles
Contact Us
Filters
Showing results (331-340 of 478) with videos related to
Page
of 48
Sort By:
American Journal of Clinical Oncology
|
February 1, 1994
Recombinant interferon alpha-2b in the treatment of diffuse malignant pleural mesothelioma
A Ardizzoni, M C Pennucci, B Castagneto, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)
E Bolli, S Saccomanno, G Mondini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
The role of lonidamine in the treatment of breast cancer patients
R Rosso, G Gardin, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer
M Venturini, P Bruzzi, L Del Mastro, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 1998
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy
S Chiara, M T Nobile, M Vincenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer
L Repetto, L Miglietta, G Gardin, et al.
Gynecologic Oncology
|
April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
E Campora, M Bruzzone, S Chiara, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
G Gardin, A Alama, R Rosso, et al.
Cancer
|
May 1, 1985
Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases
M Lazzarino, E Morra, R Rosso, et al.
Page
of 48
Search research articles
Search
Showing results (331-340 of 478) with videos related to
Sort By:
Page
of 48
American Journal of Clinical Oncology
|
February 1, 1994
Recombinant interferon alpha-2b in the treatment of diffuse malignant pleural mesothelioma
A Ardizzoni, M C Pennucci, B Castagneto, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)
E Bolli, S Saccomanno, G Mondini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
The role of lonidamine in the treatment of breast cancer patients
R Rosso, G Gardin, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer
M Venturini, P Bruzzi, L Del Mastro, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 1998
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy
S Chiara, M T Nobile, M Vincenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer
L Repetto, L Miglietta, G Gardin, et al.
Gynecologic Oncology
|
April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
E Campora, M Bruzzone, S Chiara, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
G Gardin, A Alama, R Rosso, et al.
Cancer
|
May 1, 1985
Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases
M Lazzarino, E Morra, R Rosso, et al.
Page
of 48